Meda, Apotex Come To Terms In Astelin, Optivar Suits
Swedish pharmaceutical company Meda AB has settled the litigation it brought against Canadian generics maker Apotex Inc. to protect the markets for Meda's conjunctivitis treatment Optivar and its rhinitis treatment Astelin,...To view the full article, register now.
Already a subscriber? Click here to view full article